Abnormal Β-Catenin Expression and Reduced Tumor-Infiltrating T Cells Are Related to Poor Progression in Non-Small Cell Lung Cancer.

Liang Ye,Huijuan Li,Hongying Wang,Hongbing Liu,Tangfeng Lv,Fang Zhang,Yong Song
2017-01-01
Abstract:Objective: This study was to identify the relationship between the expression of beta-catenin and CD8+ T cells infiltration in non-small cell lung cancer (NSCLC). Methods: A total of 100 NSCLC patients undergoing lobectomy and lymph node dissection were enrolled in this study. The baseline demographics, histopathologic data, recurrencefree survival (RFS) period, and pathologic specimens preserved in paraffin were available for them. Immunohistochemistry (IHC) was carried out with resected, paraffin-embedded NSCLC tissues. Evaluation of tumor-infiltrating CD8+ T cells immunostaining was performed using a four-tiered scale according to the visual estimation on lymphocytes. Results: A significant association was found between reduced beta-catenin expression and nodal involvement (P= 0.047), but no association with other characters. The RFS of patients with reduced beta-catenin expression was potently worse than that of patients with preserved beta-catenin expression (P= 0.026). Meanwhile, no significant association was observed between depressing CD8+ T cells levels and all characters. The RFS of NSCLC patients containing low CD8+ TILs was remarkably worse than those with high CD8+ T cells (P= 0.003). Multivariate analysis revealed that only CD8+ TILs was an independent predictor of RFS (P= 0.024). Moreover, CD8+ T cells level was negatively correlated with abnormal beta-catenin expression (P= 0.016). Conclusion: Abnormal beta-catenin expression might suppress antitumor activity by decreasing tumor-infiltrating CD8+ T cells. Inhibition of beta-catenin expression and/or activity might be used as a component of anti-cancer immunotherapy in the future.
What problem does this paper attempt to address?